| Editorial | Silence the gene, save the cell: RNA interference as promising therapy for ALS | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Social interaction is neuroprotective | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Miraxion Study Completed, Results Soon | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Low side effects found with elderly dementia patients taking Seroquel | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Clinical Trials Now: Time for a Pardigm Shift | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Probability of Obsessive and Compulsive Symptoms in Huntington's Disease | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | HDAC inhibitor is neuroprotective in HD mice | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | The Beneficial Effects of Blueberries | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Protein Interactions | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | FDA approves safety and tolerability trial for Dimebon | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Inhibiting the HD protein aggregates | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Tetrabenazine update | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Daniel P. Van Kammen, MD, Phd, to lead CHDI Huntington's Disease Clinical Development Effort | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | A pilot study of the clinical efficacy and safety of memantine for Huntington's disease. | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | More on Memantine | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Striosome Damage Indicted in HD Mood Disorders | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Pharmaceutical companies to invest in HDAC inhibitor research. | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | A cox-2 inhibitor shortens life in an HD mouse model | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | CoQ-10: More is Best | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Huntington's Disease Drug Works September 2004 Update | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | CAG repeats and energy metabolism | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Reducing the Effects of Stress Through Nutrition | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Mutant huntingtin alters MAPK signalling pathways | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | Low BDNF levels in serum of HD patients. | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
| Editorial | ASENT Meeting ? Notes from the Field, Day 1, Part Two | Marsha Miller Ph.D. | 0 | 5 years 30 weeks ago |
